| Application no. and date | 08755284.0 (espacenet) (Federated) (European Patent Register), 20080512 | | Patent/reg. no. and date | DK/EP 2146721, 20130710 | | Publication date | 20100127 | | Priority no. and date | US 938089 P, 20070515 | | EP pub. no. and date |
EP 2146721 20100127 | | Effective date | | | Applicant/owner | Otsuka Pharmaceutical Co., Ltd., 2-9, Kanda-Tsukasamachi
Chiyoda-ku
Tokyo 101-8535, JP | | Applicant ref. no. | P81302407DK00E | | Inventor | LIU, Yongge, c/o Otsuka Maryland Medicinal Laboratories, Inc.
9900 Medical Center Drive
Rockville, Maryland 20850, US,
KAMBAYASHI, Junichi, c/o Otsuka Maryland Medicinal Laboratories, Inc.
9900 Medical Center Drive
Rockville, Maryland 20850, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A01N 43/00 (2006.01) , A61K 31/55 (2006.01) , A61K 31/553 (2006.01) , A61K 31/554 (2006.01) , A61K 45/06 (2006.01) | | Title | FREMGANGSMÅDER TIL ANVENDELSE AF VASOPRESSINANTAGONISTER MED ANTHRACYCLIN-KEMOTERAPI-MIDLER TIL REDUKTION AF KARDIOTOKSICITET OG/ELLER FORBEDRING AF OVERLEVELSE | | Int. application no. | US2008063374 | | Int. publication no. | WO2008144269 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
